A second-generation Smoothened (Smo) antagonist has shown excellent efficacy in rodent tumor models

A second-generation Smoothened (Smo) antagonist has shown excellent efficacy in rodent tumor models
Introduction of a sulfoximine group into anticancer candidates shows that sometimes sticking to the unconventional pays off
Sipholenol analogues revealed as novel scaffolds for drugs that inhibit breast cancer cell migration and invasion
Investigation of π-stacking interactions of protein amides could improve rational drug design
Open-source compound library at GSK identifies 177 small-molecule leads for anti-tuberculois (TB) research
Development and characterization of new peptidomimetic inhibitors of the West Nile virus NS2B-NS3 protease
Butyltin(IV) benzoates show inhibition of thioredoxin reductase, interactions with proteins, and tumor cell growth inhibition
Structure–activity relationships of non-steroidal antagonist series identifies BAY 94-8862 as a potential treatment for chronic heart failure
Series of biphenyl α-D-mannosides could prevent and treat urinary tract infections (UTIs) by blocking bacterial adhesion to host cells
Miniaturized high-throughput screening assays could help identify a prophylactic strategy against liver-stage malaria